Clinical Trial Update: Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating safety and immunogenicity of a non-live, recombinant subunit herpes zoster vaccine before and after lung transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella Zoster Vaccine

Snippet

Sponsor: Deepali Kumar | Conditions: Varicella Zoster Vaccine | Phase 4 | Status: UNKNOWN